Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Health

Food packaging exposing us to microplastics in surprising ways
Health

Food packaging exposing us to microplastics in surprising ways

Highest number of particles that researchers found were in glass bottles.

Radius Care shrugs off aged care ‘crisis’
Markets

Radius Care shrugs off aged care ‘crisis’

Listed retirement providers are reducing their exposure to aged care. 

Gregor Thompson 23 Jun 2025
Mainland Capital delivers $50m raise for Chch hospital expansion
Finance

Mainland Capital delivers $50m raise for Chch hospital expansion

The oversubscribed raise will help fund a new state-of-the-art private hospital facility.

Oliver Lewis 13 Jun 2025
Green Cross Health navigates tough year with $16m profit
Markets

Green Cross Health navigates tough year with $16m profit

The company is navigating a 'challenging healthcare landscape'.

John Anthony 29 May 2025